GENEDX HOLDINGS CORP (WGS)
US81663L2007 - Common Stock
Tuesday Sector Leaders: Diagnostics, Biotechnology Stocks
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision medicine
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision...
GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024
GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024
Management will host a conference call on Monday, April 29, 2024 to discuss first quarter 2024 financial and operating results at 4:30 p.m. Eastern Time. ...
GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics
STAMFORD, Conn., March 14, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today...
GeneDx to Participate in 44th Annual Cowen Health Care Conference
GeneDx to Participate in 44th Annual Cowen Health Care Conference
GeneDx (Nasdaq: WGS) today announced that company management will participate in the Cowen Healthcare Conference from March 4-6 in Boston, MA. ...
Top Buys by Directors: Ryan's $161.4K Bet on WGS
GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024
GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024
GeneDx Holdings Corp. (Nasdaq: WGS) reported its financial results for the fourth quarter and full year of 2023....
GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024
GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024
GeneDx management will host a conference call at 4:30 p.m. Eastern Time on February 20, 2024 to discuss 2023 results and share full year 2024 guidance....
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
STAMFORD, Conn., Jan. 24, 2024 (GLOBE NEWSWIRE) -- GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, today...
Wednesday Sector Laggards: Diagnostics, Oil & Gas Refining & Marketing Stocks
GeneDx Announces Preliminary 2023 Financial Results
GeneDx Announces Preliminary 2023 Financial Results
Expects to exceed revised 2023 revenue guidance with fourth quarter 2023 revenue from continuing operations of more than $57M....
Thursday Sector Leaders: Aerospace & Defense, Diagnostics
GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy
New research from one of the largest exome sequencing studies of patients with epilepsy adds to the mounting evidence that exome sequencing offers superior clinical results compared to multi-gene panels
GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy
New research from one of the largest exome sequencing studies of patients with epilepsy adds to the mounting evidence that exome sequencing offers superior...
GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference
GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference
GeneDx company management will participate in the 6th Annual Evercore ISI HealthCONx Conference....
Top Buys by Top Brass: Executive Chairman Ryan's $161.4K Bet on WGS
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
STAMFORD, Conn., Nov. 20, 2023 (GLOBE NEWSWIRE) -- GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, today...